CVS Health CVS Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by CVS Health in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The source filing: CVS Health’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:33 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000064803-26-000098
The Company’s allowance for credit losses was $169 million and $182 million as of June 30, 2026 and December 31, 2025, respectively. When developing an estimate of the Company’s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company’s accounts receivable are short duration in nature and typically settle in less than 30 days.
Item 1.Financial Statements
FAQ
- What is CVS Health's allowance for doubtful accounts receivable (current)?
- CVS Health (CVS) reported allowance for doubtful accounts receivable (current) of $169M in Q2 2026.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.
Ask your AI about CVS Health's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
